TSCAN THERAPEUTICS INC. - COMMON STOCK

TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures

12 سبتمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

07 سبتمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress

10 أغسطس 2022 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference

03 أغسطس 2022 07:00:02 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Publication in Cell Highlighting the Discovery of Tumor Antigens and TCRs for the Treatment of Solid Tumors Using Foundational Screening Technology

11 يوليو 2022 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Appoints Debora Barton, M.D., as Chief Medical Officer

07 يوليو 2022 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium

22 يونيو 2022 07:00:01 بحسب Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the 2022 Jefferies Healthcare Conference

02 يونيو 2022 07:00:01 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-101 for the Treatment of Hematologic Malignancies

31 مايو 2022 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Presents Preclinical Data at the American Society of Gene and Cell Therapy 25th Annual Meeting

19 مايو 2022 07:00:01 بحسب Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

17 مايو 2022 07:00:02 بحسب Nasdaq GlobeNewswire

TScan Therapeutics to Host Virtual KOL Event to Discuss its Solid Tumor Program Strategy and Highlights from the ASGCT 25th Annual Meeting

12 مايو 2022 07:00:01 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Reports First Quarter 2022 Financial Results and Upcoming Anticipated Milestones

09 مايو 2022 07:00:02 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Presentations at the 25th American Society of Gene and Cell Therapy Annual Meeting

02 مايو 2022 17:02:38 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Appoints Leiden Dworak, CPA, MBA, as Vice President, Finance

11 أبريل 2022 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities

09 مارس 2022 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics to Participate in Upcoming Investor Conferences

02 مارس 2022 07:00:00 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces Presentation at the 11th Annual SVB Leerink Global Healthcare Conference

10 فبراير 2022 07:00:02 بحسب Nasdaq GlobeNewswire

TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-100 for the Treatment of Hematologic Malignancies

24 يناير 2022 07:00:01 بحسب Nasdaq GlobeNewswire

TScan Outlines 2022 Priorities as Programs Enter Clinic

10 يناير 2022 07:00:03 بحسب Nasdaq GlobeNewswire